Real-time quality Novilytic offers near-real-time protein quality insights to upstream scientists, presenting a sales opportunity to labs needing faster decision support and reduced downtime in fermentor workflows.

Early issue detection The canary in the fermentor positioning highlights the value of early anomaly detection, which can be pitched to biotech and contract research organizations seeking proactive quality control and fewer batch failures.

Strategic partnerships Past collaborations with Purdue Research Foundation and NIH SBIR funding indicate a favorable channel for partnerships, licensing discussions, and potential co-development opportunities with research institutions and university-affiliated labs.

Mid-market focus With a small- to mid-size employee base and revenue in the 10–25M range, target biotech incumbents and mid-tier analytics providers that can scale integration of Novilytic’s protein-quality insights into existing lab information systems.

Expansion momentum Being named a BTI finalist and ongoing funding/recognition suggest momentum; position as a growth partner for customers pursuing rapid deployment, expanded use cases, and enabling labs to do more with less.